495 related articles for article (PubMed ID: 32132206)
1. Assessing thyroid cancer risk using polygenic risk scores.
Liyanarachchi S; Gudmundsson J; Ferkingstad E; He H; Jonasson JG; Tragante V; Asselbergs FW; Xu L; Kiemeney LA; Netea-Maier RT; Mayordomo JI; Plantinga TS; Hjartarson H; Hrafnkelsson J; Sturgis EM; Brock P; Nabhan F; Thorleifsson G; Ringel MD; Stefansson K; de la Chapelle A
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5997-6002. PubMed ID: 32132206
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
4. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
5. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
[TBL] [Abstract][Full Text] [Related]
7. [Polygenic scores and cancer risk].
Jordan B
Med Sci (Paris); 2020 May; 36(5):535-537. PubMed ID: 32452380
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
9. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
10. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
[TBL] [Abstract][Full Text] [Related]
11. Copy Number Alterations in Papillary Thyroid Carcinomas: Does Loss of
DE Almeida DCN; DE Souza MPC; Amorim CKN; DA Silva MauÉs JH; DO E Santo Sagica F; Moreira-Nunes CA; DE Oliveira EHC
Cancer Genomics Proteomics; 2020; 17(5):643-648. PubMed ID: 32859642
[TBL] [Abstract][Full Text] [Related]
12. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
[TBL] [Abstract][Full Text] [Related]
14. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
Liu Y; Li Z; Tang X; Li M; Shi F
Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
Thomas M; Sakoda LC; Hoffmeister M; Rosenthal EA; Lee JK; van Duijnhoven FJB; Platz EA; Wu AH; Dampier CH; de la Chapelle A; Wolk A; Joshi AD; Burnett-Hartman A; Gsur A; Lindblom A; Castells A; Win AK; Namjou B; Van Guelpen B; Tangen CM; He Q; Li CI; Schafmayer C; Joshu CE; Ulrich CM; Bishop DT; Buchanan DD; Schaid D; Drew DA; Muller DC; Duggan D; Crosslin DR; Albanes D; Giovannucci EL; Larson E; Qu F; Mentch F; Giles GG; Hakonarson H; Hampel H; Stanaway IB; Figueiredo JC; Huyghe JR; Minnier J; Chang-Claude J; Hampe J; Harley JB; Visvanathan K; Curtis KR; Offit K; Li L; Le Marchand L; Vodickova L; Gunter MJ; Jenkins MA; Slattery ML; Lemire M; Woods MO; Song M; Murphy N; Lindor NM; Dikilitas O; Pharoah PDP; Campbell PT; Newcomb PA; Milne RL; MacInnis RJ; Castellví-Bel S; Ogino S; Berndt SI; Bézieau S; Thibodeau SN; Gallinger SJ; Zaidi SH; Harrison TA; Keku TO; Hudson TJ; Vymetalkova V; Moreno V; Martín V; Arndt V; Wei WQ; Chung W; Su YR; Hayes RB; White E; Vodicka P; Casey G; Gruber SB; Schoen RE; Chan AT; Potter JD; Brenner H; Jarvik GP; Corley DA; Peters U; Hsu L
Am J Hum Genet; 2020 Sep; 107(3):432-444. PubMed ID: 32758450
[TBL] [Abstract][Full Text] [Related]
16. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
17. Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
Gettler K; Levantovsky R; Moscati A; Giri M; Wu Y; Hsu NY; Chuang LS; Sazonovs A; Venkateswaran S; Korie U; Chasteau C; ; Duerr RH; Silverberg MS; Snapper SB; Daly MJ; McGovern DP; Brant SR; Rioux JD; Kugathasan S; Anderson CA; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1546-1557. PubMed ID: 33359885
[TBL] [Abstract][Full Text] [Related]
18. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.
Neta G; Yu CL; Brenner A; Gu F; Hutchinson A; Pfeiffer R; Sturgis EM; Xu L; Linet MS; Alexander BH; Chanock S; Sigurdson AJ
Laryngoscope; 2012 May; 122(5):1040-2. PubMed ID: 22275265
[TBL] [Abstract][Full Text] [Related]
20. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]